Triglyceride Glucose Index and Prognosis of Patients With Ischemic Stroke
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Background: The triglyceride glucose index (TyG index) has been proposed as a simple and credible surrogate marker of insulin resistance. However, it is unclear whether TyG index correlates with adverse clinical outcomes in patients with ischemic stroke. Accordingly, this study aimed to explore the relationship between baseline TyG index and clinical outcomes of ischemic stroke individuals. Methods: We included eligible subjects with ischemic stroke from the China National Stroke Registry II for the current analysis. TyG index was calculated and divided into quartiles to explore the relationship with the outcomes of ischemic stroke. Outcomes included stroke recurrence, all-cause mortality, poor functional outcome at 12 months, and neurologic worsening at discharge. Multivariable Cox regression and logistic regression models were performed to explore the correlation of baseline TyG index with the outcomes. Results: Among the 16310 patients enrolled in the study, the average age was 64.83±11.9 years, and 63.48% were men. The median TyG index was 8.73 (interquartile range, 8.33-9.21). After adjustment for multiple potential covariates, the fourth quartile of TyG index was associated with an increased risk of stroke recurrence (adjusted HR, 1.32; 95% CI, 1.11-1.57; P=0.002), all-cause mortality (adjusted HR, 1.25; 95%CI, 1.06–1.47; P=0.01) at 12-month follow-up, and neurological worsening (adjusted OR, 1.26; 95% CI, 1.02–1.55; P=0.03) at discharge, but not poor functional outcome compared with the first quartile. Conclusion: TyG index representing insulin resistance was associated with an increased risk of stroke recurrence, all-cause mortality, and neurologic worsening in patients with ischemic stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
Simental-Mendía, L. E., Rodríguez-Morán, M., & Guerrero-Romero, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0034 · Cited by 2,445 · cited 2×
“In recent years, TyG index has been proposed to estimate insulin sensitivity by simply assessing circulating triglyceride and glucose concentration in routine clinical practice (15).”
BackgroundGuerrero-Romero, F., Simental-Mendía, L. E., González-Ortiz, M., Martínez-Abundis, E., Ramos-Zavala, M. G., Hernández-González, S. O., Jacques-Camarena, O., & Rodríguez-Morán, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0288 · Cited by 2,247 · cited 2×
“TyG index was calculated as ln[fasting triglycerides (mg/dl) × fasting glucose (mg/ dl)/2] (16).”
BackgroundMethodPioglitazone after Ischemic Stroke or Transient Ischemic Attack
Kernan, W. N., Viscoli, C. M., Furie, K. L., Young, L. H., Inzucchi, S. E., Gorman, M., Guarino, P. D., Lovejoy, A. M., Peduzzi, P. N., Conwit, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506930 · Cited by 1,124
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Effect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050 · cited 1×
“Meanwhile, increased circulating fatty acids may also inhibit insulin activity of glucose uptake in peripheral tissues and lipolysis, leading to exacerbation of IR and the development of another vicious circle between IR and dyslipidemia (56).”
BackgroundInsulin Resistance, Hyperglycemia, and Atherosclerosis
Bornfeldt, K. E., & Tabas, I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.015 · Cited by 995
TyG index performs better than HOMA in a Brazilian population: A hyperglycemic clamp validated study
Vasques, A. C. J., Novaes, F. S., de Oliveira, M. D. S., Matos Souza, J. R., Yamanaka, A., Pareja, J. C., Tambascia, M. A., Saad, M. J. A., & Geloneze, B. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.030 · Cited by 795
Du, T., Yuan, G., Zhang, M., Zhou, X., Sun, X., & Yu, X. (2014) · Cardiovascular Diabetology · doi:10.1186/preaccept-1207347889137599 · Cited by 620
One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke
Amarenco, P., Lavallée, P. C., Labreuche, J., Albers, G. W., Bornstein, N. M., Canhão, P., Caplan, L. R., Donnan, G. A., Ferro, J. M., Hennerici, M. G., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1412981 · Cited by 602 · cited 1×
“Third, while recent studies indicated that imaging and biological markers are determinant factors to predict the prognosis of stroke (66, 67), these variables were not collected and analyzed in our study.”
ResultWilcox, R., Bousser, M.-G., Betteridge, D. J., Schernthaner, G., Pirags, V., Kupfer, S., & Dormandy, J. (2007) · Stroke · doi:10.1161/01.str.0000257974.06317.49 · Cited by 475 · cited 5×
“Furthermore, Lundstrom et al. found that a high level of IR was a pre-requisite for high on-treatment platelet reactivity in minor IS or TIA patients prescribed clopidogrel as secondary prevention, which may influence the efficacy of antiplatelet treatment and lead to poor prognosis (38).”
BackgroundInfluentialStančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db08-1607 · Cited by 348 · cited 1×
“The Metabolic Syndrome in Men study demonstrated that insulin sensitivity was already decreased substantially within the normal range of fasting plasma glucose (58).”
BackgroundIrace, C., Carallo, C., Scavelli, F. B., De Franceschi, M. S., Esposito, T., Tripolino, C., & Gnasso, A. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12124 · Cited by 326 · cited 1×
“Although previous studies have shown that TyG index is associated with carotid atherosclerosis (18), coronary artery calcification (19), coronary artery stenosis (20), and high risk of cardiovascular disease (21), it is not known whether TyG index correlates with adverse clinical outcomes in patients with IS.”
ResultWang, Y., Jing, J., Meng, X., Pan, Y., Wang, Y., Zhao, X., Lin, J., Li, W., Jiang, Y., Li, Z., et al. (2019) · Stroke and Vascular Neurology · doi:10.1136/svn-2019-000242 · Cited by 312
Self-citationAssociation between triglyceride glucose index and arterial stiffness in Korean adults
Lee, S. B., Ahn, C. W., Lee, B. K., Kang, S., Nam, J. S., You, J. H., Kim, M. J., Kim, M. K., & Park, J. S. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0692-1 · Cited by 305 · cited 1×
“Although previous studies have shown that TyG index is associated with carotid atherosclerosis (18), coronary artery calcification (19), coronary artery stenosis (20), and high risk of cardiovascular disease (21), it is not known whether TyG index correlates with adverse clinical outcomes in patients with IS.”
ResultWang, Y., Cui, L., Ji, X., Dong, Q., Zeng, J., Wang, Y., Zhou, Y., Zhao, X., Wang, C., Liu, L., et al. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00584.x · Cited by 263 · cited 1×
“The criteria for site selection in CNSR I have been previously published (25).”
BackgroundSelf-citationPlatelet activation in obesity and metabolic syndrome
Santilli, F., Vazzana, N., Liani, R., Guagnano, M. T., & Davì, G. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00930.x · Cited by 258
Diabetes mellitus and thrombosis
Vazzana, N., Ranalli, P., Cuccurullo, C., & Davì, G. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2011.11.052 · Cited by 257
Kim, M. K., Ahn, C. W., Kang, S., Nam, J. S., Kim, K. R., & Park, J. S. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0589-4 · Cited by 246 · cited 1×
“Although previous studies have shown that TyG index is associated with carotid atherosclerosis (18), coronary artery calcification (19), coronary artery stenosis (20), and high risk of cardiovascular disease (21), it is not known whether TyG index correlates with adverse clinical outcomes in patients with IS.”
ResultFasting Triglycerides and Glucose Index as a Diagnostic Test for Insulin Resistance in Young Adults
Guerrero-Romero, F., Villalobos-Molina, R., Jiménez-Flores, J. R., Simental-Mendia, L. E., Méndez-Cruz, R., Murguía-Romero, M., & Rodríguez-Morán, M. (2016) · Archives of Medical Research · doi:10.1016/j.arcmed.2016.08.012 · Cited by 244 · cited 1×
“In addition, a number of studies have identified the great correlations between TyG and hyperinsulinemic-euglycemic clamp test or HOMA-IR in different populations (16, 17, 60, 61).”
BackgroundLee, E. Y., Yang, H. K., Lee, J., Kang, B., Yang, Y., Lee, S.-H., Ko, S.-H., Ahn, Y.-B., Cha, B. Y., Yoon, K.-H., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0324-2 · Cited by 220 · cited 1×
“Although previous studies have shown that TyG index is associated with carotid atherosclerosis (18), coronary artery calcification (19), coronary artery stenosis (20), and high risk of cardiovascular disease (21), it is not known whether TyG index correlates with adverse clinical outcomes in patients with IS.”
ResultReview article: Platelet abnormalities in diabetes mellitus
Ferreiro, J. L., Gómez-Hospital, J. A., & Angiolillo, D. J. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110383994 · Cited by 216
Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents
Kang, B., Yang, Y., Lee, E. Y., Yang, H. K., Kim, H.-S., Lim, S.-Y., Lee, J.-H., Lee, S.-S., Suh, B.-K., & Yoon, K.-H. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.14 · Cited by 182 · cited 1×
“In addition, a number of studies have identified the great correlations between TyG and hyperinsulinemic-euglycemic clamp test or HOMA-IR in different populations (16, 17, 60, 61).”
BackgroundInsulin Resistance and Its Treatment by Thiazolidinediones
Lebovitz, H. E. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.265 · Cited by 181
Shi, W., Xing, L., Jing, L., Tian, Y., Yan, H., Sun, Q., Dai, D., Shi, L., & Liu, S. (2020) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.09.015 · Cited by 178
Self-citationOh, J., Riek, A. E., Darwech, I., Funai, K., Shao, J.-S., Chin, K., Sierra, O. L., Carmeliet, G., Ostlund, R. E., & Bernal‐Mizrachi, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.043 · Cited by 167
Rundek, T., Gardener, H. E., Xu, Q., Goldberg, R. B., Wright, C. B., Boden-Albala, B. M., Disla, N., Paik, M. C., Elkind, M. S. V., & Sacco, R. L. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.235 · Cited by 164
Insulin resistance and clinical outcomes after acute ischemic stroke
Ago, T., Matsuo, R., Hata, J., Wakisaka, Y., Kuroda, J., Kitazono, T., Kamouchi, M., & On behalf of the Fukuoka Stroke Registry Investigators (2018) · Neurology · doi:10.1212/wnl.0000000000005358 · Cited by 129
Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., McVeety, J. C., & Horwitz, R. I. (2003) · Neurology · doi:10.1212/01.wnl.0000063318.66140.a3 · Cited by 126 · cited 1×
“Diabetic patients were classified if either of the following criteria was met: (1) self-reported physician diagnosis of diabetes mellitus; (2) hypoglycemic medications before hospitalization.”
BackgroundJing, J., Pan, Y., Zhao, X., Zheng, H., Jia, Q., Mi, D., Chen, W., Li, H., Liu, L., Wang, C., et al. (2017) · Stroke · doi:10.1161/strokeaha.116.015613 · Cited by 121
Self-citationSubstantial Progress Yet Significant Opportunity for Improvement in Stroke Care in China
Li, Z., Wang, C., Zhao, X., Liu, L., Wang, C., Li, H., Shen, H., Liang, L., Bettger, J. P., Yang, Q., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.014143 · Cited by 119
Self-citationHaemodynamic changes in insulin-induced hypoglycaemia in normal man
Hilsted, J., Bonde-Petersen, F., N�rgaard, M.-B., Greniman, M., Christensen, N. J., Parving, H. ‐., & Suzuki, M. (1984) · Diabetologia · doi:10.1007/bf00266031 · Cited by 105 · cited 1×
“Former studies revealed that IR facilitates the progression of ischemic stroke (IS) through promoting atherosclerosis (3–5), inducing hemodynamic disturbances (6), and accelerating platelet adhesion, activation, and aggregation (7–9), which could trigger stroke recurrence in individuals with IS.”
BackgroundInsulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat.
Russell, J. C., Ahuja, S. K., Manickavel, V., Rajotte, R. V., & Amy, R. M. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.6.620 · Cited by 92
Joo, H. J., Cho, S.-A., Hong, S. J., Hur, S., Bae, J., Choi, D., Ahn, Y., Park, J., Choi, R. K., Choi, D., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0374-5 · Cited by 85
Steppan, J., Bergman, Y., Viegas, K. D., Armstrong, D., Tan, S., Wang, H., Melucci, S., Hori, D., Park, S. Y., Barreto-Ortiz, S. F., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004161 · Cited by 83
Glucose transporters: cellular links to hyperglycemia in insulin resistance and diabetes
Stringer, D. M., Zahradka, P. C., & Taylor, C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu012 · Cited by 83 · cited 1×
“As for whole-body glucose homeostasis, the expression and activity of glucose transporter are modulated by IR in multiple tissues, promoting glucose accumulation in circulation and forming hyperglycemia (52).”
BackgroundMoore, S., Williams, C. M., Brown, E. M., Blair, T. A., Harper, M. T., Coward, R. J., Poole, A. W., & Hers, I. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv132 · Cited by 83
Tang, X., Ma, W.-P., Zhan, W., Wang, X., Dong, H., Zhao, H., Yang, L., Ji, C., Han, Q., Ji, C., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20171241 · Cited by 78
Newman, J. M. B., Dwyer, R. M., St‐Pierre, P., Richards, S. M., Clark, M. G., & Rattigan, S. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.169011 · Cited by 70
Insulin Resistance, Small LDL Particles, and Risk for Atherosclerotic Disease
Toth, P. P. (2014) · Current Vascular Pharmacology · doi:10.2174/15701611113119990125 · Cited by 68 · cited 1×
“It may accelerate the progression of atherosclerosis by modifying the risk factors through inflammation and oxidative stress mechanisms and damage the cerebral metabolism (48, 49).”
BackgroundCasanova, F., Adingupu, D. D., Adams, F., Gooding, K. M., Looker, H. C., Aizawa, K., Dove, F., Elyas, S., Belch, J. J. F., Gates, P. E., et al. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0594-7 · Cited by 67
Pan, Y., Jing, J., Chen, W., Zheng, H., Jia, Q., Mi, D., Li, H., Zhao, X., Liu, L., Wang, C., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004990 · Cited by 67 · cited 1×
“In accordance with previous studies from the ACROSS-China registry (Abnormal Glucose Regulation in Patients with Acute Stroke Across China) (12, 65), the results in the main analysis of the study support that IR significantly increases the risk of stroke recurrence, all-cause mortality during the 12-month follow-up.”
ResultSelf-citationLesniewski, L. A., Donato, A. J., Behnke, B. J., Woodman, C. R., Laughlin, M. H., Ray, C. A., & Delp, M. D. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00692.2007 · Cited by 66
Association of Lp-PLA 2 -A and early recurrence of vascular events after TIA and minor stroke
Lin, J., Zheng, H., Cucchiara, B. L., Li, J., Zhao, X., Liang, X., Wang, C., Li, H., Mullen, M. T., Johnston, S. C., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001938 · Cited by 59
Self-citationSocial work support and unmet social needs in life after stroke: a cross-sectional exploratory study
on behalf of the BSA Long Term Care Study Group, Lehnerer, S., Hotter, B. A., Padberg, I., Knispel, P., Remstedt, D., Liebenau, A., Grittner, U., Wellwood, I., & Meisel, A. (2019) · BMC Neurology · doi:10.1186/s12883-019-1451-y · Cited by 57
Insulin Resistance and the Risk of Stroke and Stroke Subtypes in the Nondiabetic Elderly
Wieberdink, R. G., Koudstaal, P. J., Hofman, A., Witteman, J. C. M., Breteler, M. M. B., & Ikram, M. A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws149 · Cited by 54
Thacker, E. L., Psaty, B. M., McKnight, B., Heckbert, S. R., Longstreth, W. T., Mukamal, K. J., Meigs, J. B., de Boer, I. H., Boyko, E. J., Carnethon, M. R., et al. (2011) · Stroke · doi:10.1161/strokeaha.111.620773 · Cited by 52
Ning, B., Wang, X., Yu, Y., Waqar, A. B., Yu, Q., Koike, T., Shiomi, M., Liu, E., Wang, Y., & Fan, J. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0024-3 · Cited by 51
Self-citationChiu, C.-C., Wu, S.-S., Lee, P.-Y., Huang, Y., Tan, T., & Chang, K. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00940.x · Cited by 51
Potier, L., Chequer, R. D. P., Roussel, R., Mohammedi, K., Sismail, S., Hartemann, A., Amouyal, C., Marre, M., Guludec, D. L., & Hyafil, F. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0652-1 · Cited by 50
Kain, K., Catto, A. J., & Grant, P. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00958.x · Cited by 50
Flemming, K. D., & Brown, R. D. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.10.1330 · Cited by 47
Fitzgibbons, T. P., & Czech, M. P. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1385-4 · Cited by 45
Howard, G., Wagenknecht, L. E., Kernan, W. N., Cushman, M., Thacker, E. L., Judd, S. E., Howard, V. J., & Kissela, B. M. (2014) · Stroke · doi:10.1161/strokeaha.114.005306 · Cited by 42
Gast, K. B., Smit, J. W. A., den Heijer, M., Middeldorp, S., Rippe, R. C. A., le Cessie, S., de Koning, E. J. P., Jukema, J. W., Rabelink, T. J., Roos, A., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.021 · Cited by 38
Early atherogenesis and visceral fat in obese adolescents
Slyper, A. H., Rosenberg, H., Kabra, A., Weiss, M. J., Blech, B., Gensler, S., & Matsumura, M. E. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.11 · Cited by 37
López‐de‐Andrés, A., Jiménez‐García, R., Hernández‐Barrera, V., Pérez-Farinós, N., de Miguel-Yanes, J. M., Méndez‐Bailón, M., Jiménez‐Trujillo, I., de Miguel, Á. G., Pino, C. G., & Carrasco‐Garrido, P. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-3 · Cited by 36
Neuhauser, H. K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67780-x · Cited by 33
Li, S., Yin, C., Zhao, W., Zhu, H., Xu, D., Xu, Q. Y., Jiao, Y., Wang, X., & Qiao, H. (2018) · Bioscience Reports · doi:10.1042/bsr20180330 · Cited by 31
Lundström, A., Laska, A. C., von Arbin, M., Jörneskog, G., & Wallén, H. (2013) · Platelets · doi:10.3109/09537104.2013.777951 · Cited by 30
Pham, N., Dhar, A., Khalaj, S., Desai, K., & Taghibiglou, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.04.071 · Cited by 24
Catto, A. J., Grant, P. J., & Kain, K. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613339 · Cited by 19
Åberg, D., Åberg, N. D., Jood, K., Holmegaard, L., Redfors, P., Blomstrand, C., Isgaard, J., Jern, C., & Svensson, J. (2019) · BMC Neurology · doi:10.1186/s12883-019-1406-3 · Cited by 19 · cited 1×
“To date, previous studies mostly used HOMA-IR for the assessment of IR to evaluate the correlation between IR and clinical outcomes in patients with IS (13, 50, 51).”
MethodDyslipidaemias, Insulin Resistance and Atherosclerosis
Laakso, M. (1992) · Annals of Medicine · doi:10.3109/07853899209167003 · Cited by 17
İnce, H., Taşdemir, H. A., Aydın, M., Özyürek, H., & Tilki, H. E. (2014) · Journal of Child Neurology · doi:10.1177/0883073814550188 · Cited by 15
Jotić, A., Milicic, T. J., Sternic, N. C., Kostić, V., Lalic, K. S., Jeremic, V., Mijajlovic, M. D., Lukić, L., Rajkovic, N., Čivčić, M., et al. (2015) · International Journal of Endocrinology · doi:10.1155/2015/934791 · Cited by 15
Ueno, M., Fujita, K., Yamamoto, H., Ikeda, T., Suga, T., Yamaji, K., Ikuta, S., Kobuke, K., Iwanaga, Y., Angiolillo, D. J., et al. (2015) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-015-1177-7 · Cited by 11
Kostiuk, E. P., & Зубкова, С. Т. (1994) · PubMed · Cited by 3
Research works printed but not linked: 5
- Toyoda, 2009, Acute blood pressure levels and neurological deterioration in different subtypes of ischemic stroke, Stroke., 40, 2585, 10.1161/STROKEAHA.108.543587 · doi:10.1161/strokeaha.108.543587
- Chazova, 2004, [Cerebrovascular complications in metabolic syndrome: possible approaches to decrease risk], Ter Arkh., 76, 74
- Chazova, 2005, [Cerebral perfusion in patients with metabolic syndrome], 8
- Khan, 2009, Ischemic stroke: prevalence of modifiable risk factors in male and female patients in Pakistan, Pak J Pharm Sci., 22, 62
- Yki-jarvinen, 1992, Glucose toxicity, Endocr Rev, 13, 415, 10.1210/edrv-13-3-415 · DOI
Cited by
Liu, X., Tan, Z., Huang, Y., Zhao, H., Liu, M., Yu, P., Ma, J., Zhao, Y., Zhu, W., & Wang, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01546-0 · Cited by 409
The impact of triglyceride-glucose index on ischemic stroke: a systematic review and meta-analysis
Yang, Y., Huang, X., Wang, Y., Leng, L., Xu, J., Feng, L., Jiang, S., Wang, J., Yang, Y., Pan, G., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01732-0 · Cited by 288
Self-citation
Metadata
- Authors
- Zhou, Y., Pan, Y., Yan, H., Wang, Y., Li, Z., Zhao, X., Li, H., Meng, X., Wang, C., Liu, L., & Wang, Y.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-10
- Volume
- 11
- Pages
- 456-456
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W3034377521
- Cited by
- 159
- References
- 69
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.